Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis

Global Health Action
Patrick McMullanAmitava Banerjee

Abstract

In India, 50-65% of the population face difficulties in accessing medicines. The Health Impact Fund (HIF) is a novel proposal whereby pharmaceutical companies would be paid based on the measured global health impact of their drugs. We conducted a key stakeholder analysis to explore access to medicines in India, acceptability of the HIF and potential barriers and facilitators at policy level. To conduct a stakeholder analysis of the HIF in India: to determine key stakeholder views regarding access to medicines in India; to evaluate acceptability of the HIF; and to assess potential barriers and facilitators to the HIF as a policy. In New Delhi, we conducted semi-structured interviews. There was purposive recruitment of participants with snowball sampling. Transcribed data were analysed using stakeholder analysis frameworks and directed content analysis. Participation rate was 29% (14/49). 14 semi-structured interviews were conducted among stakeholders in New Delhi. All participants highlighted access to medicines as a problem in India. There were mixed views about the HIF in terms of relevance and scaleability. Stakeholders felt it should focus on diseases with limited or no market and potentially incorporate direct investment in...Continue Reading

References

Dec 1, 1994·Research in Nursing & Health·M Sandelowski
Sep 30, 2000·Health Policy and Planning·Z Varvasovszky, R Brugha
Jan 5, 2002·Journal of Health Politics, Policy and Law·U E Reinhardt
Apr 24, 2003·Clinical Pharmacology and Therapeutics·Jonathan D Quick
Oct 6, 2005·Qualitative Health Research·Hsiu-Fang Hsieh, Sarah E Shannon
Sep 18, 2007·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Allison TongJonathan Craig
Dec 2, 2009·Nature Reviews. Drug Discovery·Bernard Munos
Jan 30, 2010·Lancet·Amitava BanerjeeThomas Pogge
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Jun 25, 2010·European Journal of Public Health·Cécile KnaiIveta Pudule
Jan 14, 2011·Lancet·K Srinath ReddyUNKNOWN Lancet India Group for Universal Healthcare
Jun 2, 2012·Health Policy·Fevzi AkinciFatma Oğücü
Nov 24, 2012·Health Policy and Planning·Maryam BigdeliWim Van Damme
Apr 5, 2013·Pharmacotherapy·Ilya M DanelichJo E Rodgers
May 11, 2013·Journal of Pharmacology & Pharmacotherapeutics·Dipika Bansal, Vilok K Purohit
Sep 27, 2014·Health Policy and Planning·Catherine E Vialle-ValentinDennis Ross-Degnan
Jun 17, 2015·International Journal of Health Services : Planning, Administration, Evaluation·Youn Jung, Soonman Kwon
Aug 20, 2015·Journal of Family Medicine and Primary Care·Philip Mathew
Sep 12, 2015·Health Affairs·Sandeep P KishoreRachel Kiddell-Monroe
May 23, 2017·Lancet·UNKNOWN GBD 2015 Healthcare Access and Quality Collaborators. Electronic address: cjlm@uw.edu, UNKNOWN GBD 2015 Healthcare Access and Quality Collaborators
Jul 1, 2015·WHO South-East Asia Journal of Public Health·Sanjay ZodpeyAnjali Sharma

❮ Previous
Next ❯

Software Mentioned

NVivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Kidney & Blood Pressure Research
Christian RosenbergerSamuel N Heyman
Current Oncology Reports
Jaleh Fallah, Brian I Rini
Seminars in Cell & Developmental Biology
P H Maxwell
© 2022 Meta ULC. All rights reserved